Literature DB >> 35348641

Immunometabolic adaptation and immune plasticity in pregnancy and the bi-directional effects of obesity.

April Rees1, Oliver Richards1, Megan Chambers1, Benjamin J Jenkins1, James G Cronin1, Catherine A Thornton1.   

Abstract

Mandatory maternal metabolic and immunological changes are essential to pregnancy success. Parallel changes in metabolism and immune function make immunometabolism an attractive mechanism to enable dynamic immune adaptation during pregnancy. Immunometabolism is a burgeoning field with the underlying principle being that cellular metabolism underpins immune cell function. With whole body changes to the metabolism of carbohydrates, protein and lipids well recognised to occur in pregnancy and our growing understanding of immunometabolism as a determinant of immunoinflammatory effector responses, it would seem reasonable to expect immune plasticity during pregnancy to be linked to changes in the availability and handling of multiple nutrient energy sources by immune cells. While studies of immunometabolism in pregnancy are only just beginning, the recognised bi-directional interaction between metabolism and immune function in the metabolic disorder obesity might provide some of the earliest insights into the role of immunometabolism in immune plasticity in pregnancy. Characterised by chronic low-grade inflammation including in pregnant women, obesity is associated with numerous adverse outcomes during pregnancy and beyond for both mother and child. Concurrent changes in metabolism and immunoinflammation are consistently described but any causative link is not well established. Here we provide an overview of the metabolic and immunological changes that occur in pregnancy and how these might contribute to healthy versus adverse pregnancy outcomes with special consideration of possible interactions with obesity.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  immunometabolism; obesity; plasticity; pregnancy

Mesh:

Year:  2022        PMID: 35348641      PMCID: PMC9188350          DOI: 10.1093/cei/uxac003

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  213 in total

1.  CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.

Authors:  Juliana Camacho-Pereira; Mariana G Tarragó; Claudia C S Chini; Veronica Nin; Carlos Escande; Gina M Warner; Amrutesh S Puranik; Renee A Schoon; Joel M Reid; Antonio Galina; Eduardo N Chini
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

2.  Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines.

Authors:  Patrizia Luppi; Julie A Deloia
Journal:  Clin Immunol       Date:  2005-12-05       Impact factor: 3.969

3.  Free leptin is increased in normal pregnancy and further increased in preeclampsia.

Authors:  R J Teppa; R B Ness; W R Crombleholme; J M Roberts
Journal:  Metabolism       Date:  2000-08       Impact factor: 8.694

4.  Seminal CD38 is a pivotal regulator for fetomaternal tolerance.

Authors:  Byung-Ju Kim; Yun-Min Choi; So-Young Rah; Dae-Ryoung Park; Seon-Ah Park; Yun-Jo Chung; Seung-Moon Park; Jong Kwan Park; Kyu Yun Jang; Uh-Hyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-15       Impact factor: 11.205

Review 5.  Role of leptin in pregnancy: consequences of maternal obesity.

Authors:  D R Tessier; Z M Ferraro; A Gruslin
Journal:  Placenta       Date:  2013-01-16       Impact factor: 3.481

6.  Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat.

Authors:  Jeremy E Davis; Nicholas K Gabler; Jennifer Walker-Daniels; Michael E Spurlock
Journal:  Obesity (Silver Spring)       Date:  2008-04-10       Impact factor: 5.002

7.  Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles.

Authors:  Sarah J Germain; Gavin P Sacks; Suren R Sooranna; Suren R Soorana; Ian L Sargent; Christopher W Redman
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

8.  Maternal obesity and risk of gestational diabetes mellitus.

Authors:  Susan Y Chu; William M Callaghan; Shin Y Kim; Christopher H Schmid; Joseph Lau; Lucinda J England; Patricia M Dietz
Journal:  Diabetes Care       Date:  2007-04-06       Impact factor: 19.112

9.  CD38 deficiency suppresses adipogenesis and lipogenesis in adipose tissues through activating Sirt1/PPARγ signaling pathway.

Authors:  Ling-Fang Wang; Lian-Jie Miao; Xiao-Nv Wang; Cong-Cong Huang; Yi-Song Qian; Xuan Huang; Xiao-Lei Wang; Wan-Zhu Jin; Guang-Ju Ji; Mingui Fu; Ke-Yu Deng; Hong-Bo Xin
Journal:  J Cell Mol Med       Date:  2017-08-16       Impact factor: 5.310

10.  Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome.

Authors:  Carlos Escande; Veronica Nin; Nathan L Price; Verena Capellini; Ana P Gomes; Maria Thereza Barbosa; Luke O'Neil; Thomas A White; David A Sinclair; Eduardo N Chini
Journal:  Diabetes       Date:  2012-11-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.